USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth

Participants:

Adam Cohen Chief Scientist, National Health Mission AreaJohns Hopkins Applied Physics Lab
Adam Cohen
Chief Scientist, National Health Mission AreaJohns Hopkins Applied Physics Lab
Brian Nahed Neurosurgeon and Program DirectorMassachusetts General Hospital
Brian Nahed
Neurosurgeon and Program DirectorMassachusetts General Hospital
Benjamin Alouf Chief Medical OfficerFloreo
Benjamin Alouf
Chief Medical OfficerFloreo
Cathy Zaremba Director, Product MarketingBrightInsight
Cathy Zaremba
Director, Product MarketingBrightInsight
Cédric Odje InvestorDebiopharm Innovation Fund SA
Cédric Odje
InvestorDebiopharm Innovation Fund SA
Danny Sands Chief Medical OfficerWKD.SMRT
Danny Sands
Chief Medical OfficerWKD.SMRT
Eva de Reuver Project coordinatorRoche
Eva de Reuver
Project coordinatorRoche
Gabriele Tundo PartnerPlexus Ventures
Gabriele Tundo
PartnerPlexus Ventures
Gaurav Shah Director - Business Development TransactionsBristol-Myers Squibb
Gaurav Shah
Director - Business Development TransactionsBristol-Myers Squibb
Jonathan Lake Senior Director, Digital Endpoint ConsultantActiGraph
Jonathan Lake
Senior Director, Digital Endpoint ConsultantActiGraph
Mansa Shroff Director of Business Dev & Chief of StaffWKD.SMRT
Mansa Shroff
Director of Business Dev & Chief of StaffWKD.SMRT
Masayuki ‘Masa’ Asano Head of Partnership and Business DevelopmentMelon Inc.
Masayuki ‘Masa’ Asano
Head of Partnership and Business DevelopmentMelon Inc.
Nigel Teh Assistant Vice President, Digital HealthClavystBio
Nigel Teh
Assistant Vice President, Digital HealthClavystBio
Patrick Leyseele Founder3.life
Patrick Leyseele
Founder3.life
Rafael Lira Carrillo Digital Innovation Hub ManagerMerz Therapeutics
Rafael Lira Carrillo
Digital Innovation Hub ManagerMerz Therapeutics
Sheena Dempsey Chief Solutions Officer Indivi
Sheena Dempsey
Chief Solutions Officer Indivi
Shi Kang Ng CEOEigenSensor
Shi Kang Ng
CEOEigenSensor
Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRoche
Ventsislav Dobrev
Global Clinical Lead Digital BiomarkersRoche
Wen Dombrowski MD MBA Chief Convergence OfficerCATALAIZE
Wen Dombrowski MD MBA
Chief Convergence OfficerCATALAIZE

About this Meeting

Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment. In the face of such complexity, emerging digital biomarkers, powered by advanced technology and comprehensive data analytics, offer great promise. They unlock a novel pathway to insights, facilitating not just early detection but also more adept management of neurological conditions. By harnessing data from devices and specific sensors, digital biomarkers are paving the way towards precision diagnostics and tailor-made therapeutic strategies.

If you are interested in the potential of digital biomarkers in neurology, and learning how to harness them effectively, join this roundtable discussion, anchored by Brian Nahed (Neurosurgeon and Program Director, Massachusetts General Hospital). The conversation will cover:

  • Harnessing Digital Biomarkers for Neurology: How can we best identify and use digital biomarkers for the early detection of neurological disorders? Which conditions hold the most potential, and what biomarkers are most suitable? 
  • Validation of Digital Biomarkers: Which digital biomarkers have already demonstrated their efficacy in neurology, and what regulatory guidelines and considerations are required?
  • Limitations of Current Digital Biomarkers: What practical applications and limitations exist for neurological biomarkers, and how to overcome these challenges?
  • Future of Digital Biomarkers in Neurology: What groundwork is required for these digital biomarkers to become standard tools for neurologists?
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day